Nutritional outcomes in pediatric liver transplantation: a longitudinal analysis of anthropometric measures

Guilherme Baptistello1, Thais Oliveira de Sousa1, Melina Melere2

  • 1Universidade Federal de Santa Catarina, Araranguá, SC, Brazil.

Insights

Liver transplantation significantly improves nutritional status in pediatric patients. Malnourished children typically achieve a healthy weight (eutrophy) within 7.5 months post-transplant.

Area of Science:

  • Pediatric Gastroenterology
  • Transplant Surgery
  • Nutritional Science

Background:

  • Liver transplantation is a critical intervention for end-stage liver disease in children.
  • Nutritional status is a key determinant of post-transplant outcomes.
  • Pre-transplant malnutrition is common in pediatric liver transplant candidates.

Purpose of the Study:

  • To assess nutritional outcomes in pediatric liver transplant recipients.
  • To compare nutritional status before and after liver transplantation.
  • To determine the time to nutritional recovery (eutrophy) in malnourished patients.

Main Methods:

  • Retrospective longitudinal study of 66 pediatric liver transplant patients.
  • Analysis of anthropometric data (weight, height, BMI-for-age) using WHO Z-scores.
  • Statistical analysis included paired Student's t-test and Kaplan-Meier survival curves.

Main Results:

  • Pre-transplant malnutrition affected 43.94% of patients.
  • Significant improvements in mean weight, height, and BMI post-transplant (p<0.0001).
  • Mean time to achieve eutrophy was 228 days (approximately 7.5 months).

Conclusions:

  • Liver transplantation leads to substantial improvements in pediatric nutritional status.
  • Anthropometric parameters significantly enhance after the procedure.
  • Nutritional rehabilitation is achievable within months following liver transplantation.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
307
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
279